A change in the pricing structure for Monsanto’s biotechnology seed products will be showing up on seed invoices starting with next spring’s crops. Instead of farmers seeing a line item covering technology fees on an invoice, the company is shifting to a royalty pricing structure that will be paid by seed companies licensed to market these products.